For comments, suggestions
Created with Raphaël 2.1.0 28.04.2016 Filing date 20.10.2017 Validation fee payment 30.04.2018 (A1) Patent application published 30.04.2021 AGEPI application filing date 31.08.2021 (T2) Translation of the validated European patent 29.04.2025 28.04.2026 Valid until 29.04.2027 Renewal fee to be paid until 28.04.2036 Patent will expire on

Patent in force


(210)Number of the EPO application16723204
(220)Filing date of the EPO application2016.04.28
(80)EPO patent specification publication (B)EPB nr. 08/2021, 2021.02.24
(110)EPO patent number3288940
(11)Number of the documentMD 3288940 T2
(21)Number of the applicatione 2018 0234
(71)Name(s) of applicant(s), code of the countryJANSSEN PHARMACEUTICA NV, BE;
(72)Name(s) of inventor(s), code of the countryBERRY Cynthia G.B., US;
CHEN Gang, US;
JOURDAN Fabrice Loic, ES;
LEBOLD Terry Patrick, US;
LIN David Wei, US;
PENA PIÑÓN Miguel Angel, ES;
RAVULA Suchitra, US;
SAVALL Bradley M., US;
SWANSON Devin M., US;
WU Dongpei, US;
ZHANG Wei, US;
AMERIKS Michael K., US;
(73)Name(s) of owner(s), code of the countryJANSSEN PHARMACEUTICA NV, BE;
(54)Title of the inventionAzabenzimidazoles and their use as AMPA receptor modulators
(13)Kind-of-document code T2
(51)International Patent Classification C07D 471/04 (2006.01.01); A61K 31/437 (2006.01.01); C07D 471/14 (2006.01.01); A61P 25/00 (2006.01.01); A61P 29/00 (2006.01.01)
(19)CountryBE
(41)Date of publication of the application2018.04.30
(49)Date of publication of the translation of the validated European patent specification2021.08.31
(30)Priority201562154313 P, 2015.04.29, US
(74)Patent attorney(Procedură) PARASCA Dumitru, str. Eminescu nr. 40, ap. 13, c/p 28, MD-2012, Chişinău, Republica Moldova
(86)International applicationPCT/US2016/029801, 2016.04.28
(87)International publicationWO 2016/176460, 2016.11.03
Up
/Inventions/details/3288940